Reaction profile

The FDA adverse-event record for impaired gastric function

Name: Impaired gastric function - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

85 FDA adverse-event reports reference impaired gastric function (VeDDRA 1894). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.

#1474 of 2,481
by report volume (all reactions): 85
reports citing this reaction: 27.1%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Impaired gastric function has 85 reports now versus 84 in that prior snapshot: 1 more (1.2%).

Report change: +1
Death-coded reports: +1
Death-coded share: +0.9 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Impaired gastric function changes

FDA AER · VeDDRA plate

Code 1894 VOL-LOW

VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-LOW 85 reports
DEATH-HOT 27.1%
MID-PACK #1474/2481
PHOTO-FINISH Dental plaque
SPECIES-DOG Dog · 64
DRUG-LEAD Maropitant Citrate · 24
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Dental plaque (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Report-volume neighbourhood around Impaired gastric function

Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.

FDA AER report volume · neighbourhood around Impaired gastric function

Impaired gastric function: high death-coded share in the FDA AER plate

Signature read: Impaired gastric function's 27.1% death-coded share is among the highest in the openFDA reaction corpus. Report volume sits in the middle third of the reaction corpus. Death-coded share is upper-third: 23 of 85 reports (27.1% of named reports). Nearest volume peer: Dental plaque (±0 reports). Lead species Dog (64). Lead co-reported drug Maropitant Citrate (24).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 64

Horse 12

Cat 6

Human 2

Cattle 1

Breeds Most Affected

Retriever - Labrador 11

Shepherd Dog - German 4

Retriever - Chesapeake Bay 3

Dachshund (unspecified) 3

Domestic Shorthair 3

Terrier - Yorkshire 3

Shepherd Dog - Australian 3

Retriever (unspecified) 2

Dog (unknown) 2

Cat (unknown) 2

Associated Drugs

Maropitant Citrate 24

Milbemycin Oxime + Spinosad 9

Carprofen 7

Meloxicam 7

Deracoxib 6

Trilostane 5

Tramadol 5

Ivermectin 4

Metronidazole 4

Metoclopramide 4

Famotidine 4

Polysulfated Glycosaminoglycan 4

Grapiprant 4

Milbemycin Oxime + Praziquantel 4

Butorphanol 4

Moxidectin 3

Selamectin 3

Cefovecin 3

Fluralaner 3

Maropitant 3

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Impaired gastric function, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (85 here).

Dental plaque 85 INEFFECTIVE, WEIGHT INC 85 Leukaemia 85 Pupil disorder 85

Similar death-coded share

Nearest other reactions by death-coded share (27.1% here), distinct from the volume row.

Lymphadenopathy 27.0% Peripheral nervous system disorder NOS 27.0% Thyroid gland disorder NOS 27.0% Oedema of the extremities (see also other SOCs for most applicable oedema) 27.0%

What to do with this reaction

Compare Impaired gastric function's report profile against similar reactions nationwide. See similar reactions
Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Impaired gastric function (#1474 of 2,481 by report volume); death-coded 27.1%. PlainBreed reaction plate · death-coded share stamp 27.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →